Metropolitan Life Insurance Company (MetLife)’s eGain EGAN Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio EGAN Stock Details EGAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-112	Closed	-$722	–	653
2024 Q1	$722	Sell	112 -1,045	-90%	-$7.17K	﹤0.01%	2301
2023 Q4	$9.64K	Hold	1,157	–	–	﹤0.01%	2192
2023 Q3	$7.09K	Hold	1,157	–	–	﹤0.01%	2351
2023 Q2	$8.67K	Hold	1,157	–	–	﹤0.01%	2378
2023 Q1	$8.78K	Sell	1,157 -169	-13%	-$1.45K	﹤0.01%	2202
2022 Q4	$12K	Buy	+1,326	New	+$10.9K	﹤0.01%	2226
2022 Q3	–	Sell	-1,336	Closed	-$13K	–	2321
2022 Q2	$13K	Hold	1,336	–	–	﹤0.01%	2247
2022 Q1	$15.5K	Buy	+1,336	New	+$15K	﹤0.01%	2200
2020 Q4	–	Sell	-6,934	Closed	-$98.3K	–	2547
2020 Q3	$98.3K	Sell	6,934 -159	-2%	-$1.85K	﹤0.01%	2228
2020 Q2	$78.8K	Buy	+7,093	New	+$64.6K	﹤0.01%	2385
2013 Q4	–	Sell	-11,606	Closed	-$175K	–	2743
2013 Q3	$175K	Sell	11,606 -20,218	-64%	-$241K	﹤0.01%	2518
2013 Q2	$306K	Buy	+31,824	New	+$260K	﹤0.01%	2029

Other funds holding EGAN

OCMI

Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return

KWM

Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAM

Bullseye Asset Management Denver, Colorado $197M AUM 20.63% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s EGAN Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of eGain (EGAN) in Q2 2024, closing a stake of 112 shares — an estimated $722 sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in EGAN in Q2 2013 and held it in 12 quarters. The position peaked at $306K in Q2 2013. 86 funds tracked by Wall St. Rank hold EGAN as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining eGain position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 112 eGain shares in Q2 2024, an estimated $722.
Metropolitan Life Insurance Company (MetLife) first reported a position in eGain in Q2 2013 and held it in 12 quarters.
Metropolitan Life Insurance Company (MetLife)'s eGain position peaked at $306K in Q2 2013.
86 funds tracked by Wall St. Rank held eGain as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.